# Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Study · id `cardio:ct-nct06653348` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06653348](<https://clinicaltrials.gov/study/NCT06653348>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06653348

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06653348. Randomized; single masking; primary purpose prevention. Start 2024-04-01 (actual); primary completion 2026-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06653348, source copy `cardio:ctgov-nct06653348-2025-04-27`, retrieved 2026-10-26)
- Started: 2024-04-01 (actual) (ClinicalTrials.gov record NCT06653348, source copy `cardio:ctgov-nct06653348-2025-04-27`, retrieved 2026-10-26)
- Primary completion: 2026-07-01 (anticipated) (ClinicalTrials.gov record NCT06653348, source copy `cardio:ctgov-nct06653348-2025-04-27`, retrieved 2026-10-26)
- Completion: 2026-08-01 (anticipated) (ClinicalTrials.gov record NCT06653348, source copy `cardio:ctgov-nct06653348-2025-04-27`, retrieved 2026-10-26)
- Countries: Iran (ClinicalTrials.gov record NCT06653348, source copy `cardio:ctgov-nct06653348-2025-04-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06653348-2025-04-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke
- Acronym: DEDAPT-TICA
- Condition: Ischemic Stroke
- Condition: Transient Ischemic Attack
- Intervention (Drug): Ticagrelor 60 + Aspirin
- Intervention (Drug): Ticagrelor 90 + aspirin
- Lead sponsor: Mazandaran University of Medical Sciences
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 28450b9e9973ddc4ecd3c9e692c43b314466e17bb7bd90a7b295923e583cec07
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
